As of 2025-07-08, the Relative Valuation of Oncolytics Biotech Inc (ONC.TO) is (0.13) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.15 CAD, the upside of Oncolytics Biotech Inc based on Relative Valuation is -111.6%.
The range of the Relative Valuation is (0.08) - (0.18) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.2x - 0.6x | 0.4x |
| Forward P/E multiples | 0.2x - 0.5x | 0.4x |
| Fair Price | (0.08) - (0.18) | (0.13) |
| Upside | -106.8% - -115.4% | -111.6% |
| Date | P/E |
| 2025-07-04 | -3.24 |
| 2025-07-03 | -3.50 |
| 2025-07-02 | -2.96 |
| 2025-06-30 | -2.93 |
| 2025-06-27 | -2.93 |
| 2025-06-26 | -2.76 |
| 2025-06-25 | -2.62 |
| 2025-06-24 | -2.62 |
| 2025-06-23 | -2.42 |
| 2025-06-20 | -2.71 |
| 2025-06-19 | -2.73 |
| 2025-06-18 | -2.85 |
| 2025-06-17 | -2.51 |
| 2025-06-16 | -2.45 |
| 2025-06-13 | -2.31 |
| 2025-06-12 | -2.17 |
| 2025-06-11 | -2.14 |
| 2025-06-10 | -1.61 |
| 2025-06-09 | -1.66 |
| 2025-06-06 | -1.38 |
| 2025-06-05 | -1.27 |
| 2025-06-04 | -1.30 |
| 2025-06-03 | -1.31 |
| 2025-06-02 | -1.30 |
| 2025-05-30 | -1.30 |
| 2025-05-29 | -1.40 |
| 2025-05-28 | -1.47 |
| 2025-05-27 | -1.58 |
| 2025-05-26 | -1.64 |
| 2025-05-23 | -1.55 |
| 2025-05-22 | -1.58 |
| 2025-05-21 | -1.64 |
| 2025-05-20 | -1.69 |
| 2025-05-16 | -1.83 |
| 2025-05-15 | -1.95 |
| 2025-05-14 | -2.00 |
| 2025-05-13 | -2.03 |
| 2025-05-12 | -2.09 |
| 2025-05-09 | -2.00 |
| 2025-05-08 | -2.03 |
| 2025-05-07 | -1.97 |
| 2025-05-06 | -1.97 |
| 2025-05-05 | -2.06 |
| 2025-05-02 | -2.11 |
| 2025-05-01 | -2.20 |
| 2025-04-30 | -2.17 |
| 2025-04-29 | -2.31 |
| 2025-04-28 | -2.17 |
| 2025-04-25 | -2.17 |
| 2025-04-24 | -2.28 |